| Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 | Mar'18 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||||
Depreciation and amortization expense | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Provision for bad debts and product returns | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Provision for inventory write-downs | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Amortization of deferred revenue | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Deferred income tax benefit | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Stock-based compensation | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Other | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Change in assets and liabilities: | ||||||
Accounts receivable | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Inventories | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Accounts payable | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Accrued expenses | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Deferred revenue | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Other operating assets and liabilities | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net cash (used in) provided by operating activities | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Patent and acquired intangible asset costs | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net cash used in investing activities | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Cash flows from financing activities: | ||||||
Proceeds from exercise of common stock options | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Proceeds from long-term obligations | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Payments of debt issuance costs | ||||||
0 | 0 | 0 | - | - | - | |
Payments on long-term obligations | ||||||
- | - | - | 0 | 0 | 0 | |
Net cash provided by financing activities | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Effect of exchange rate changes on cash and cash equivalents | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net decrease in cash and cash equivalents | ||||||
- | 0 | 0 | - | 0 | 0 | |
Supplemental cash flow disclosure: | ||||||
Cash paid for interest | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Income tax refunds, net of payments | ||||||
0 | 0 | 0 | - | - | - | |
Non-cash acquisition of property, plant and equipment | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Increase in accrual for dividend payable | ||||||
- | - | - | 0 | 0 | 0 | |
Non-cash common stock issuance | ||||||
0 | 0 | 0 | - | - | - | |
Zyga Technology Inc [Member] | ||||||
Payments to acquire businesses | ||||||
- | - | - | 0 | 0 | 0 | |
Paradigm Spine [Member] | ||||||
Payments to acquire businesses | ||||||
0 | 0 | 0 | - | - | - | |
Non-cash acquisition of Paradigm Spine | ||||||
0 | 0 | 0 | - | - | - | |